Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […]
Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Mark Coleman sold 5,249 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.21, for a total value of $394,777.29. Following the completion of the transaction, the director now directly owns 19,848 shares in […]
Axsome Therapeutics to Participate in Upcoming Investor Conferences marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.